Coping with COVID-19

Dermatologists and aesthetic physicians discuss what their practices look like as they re-open or plan to re-open. They share tips for keeping themselves, their staff, and their patients safe, which procedures they're likely to perform, and how the patient experience may change in a post-COVID-19 world.

How quickly will the aesthetic and dermatology markets bounce back? What will be the long-term implications of COVID-19 on patient volume, revenue, staffing, and more for practices? Experts look ahead and make predictions for what the future could look like.

Featuring: Joel L. Cohen, MD; Doris Day, MD; Steve Dayan, MD; Michael Gold, MD; Mark S. Nestor, MD, PhD; Joel Schlessinger, MD; and Amy Taub, MD

Self-care is important in an era of isolation and uncertainty. Panelists discuss a role for dietary supplements, nutrition, and sleep. Discover how much sleep individuals need and how stress and alcohol affect sleep rhythms.

Even as some aesthetic practices start to reopen, practices aren't likely to look the same. In part 3, aesthetic physicians discuss why high-volume, high-touch practices won't be possible in the near future, as well as other challenges that practices will face.

How will aesthetic meetings and aesthetic medical education look post COVID-19? How will industry relationships change? In part 2, aesthetic physicians offer insights on the role of virtual meetings, when in-person meetings could start again, and how they will work with industry.

The COVID-19 pandemic has forced practice closures and a halt to aesthetic procedures, but virtual consults and educational webinars can keep dermatologists and aesthetic physicians connected to their patients. Sabrina Fabi, MD and Dhaval Bhanusali, MD share insights into what's working for them and the benefits they're seeing.

Wendy Lewis, Anthony Youn, MD, and Jason Bloom, MD, discuss when and how aesthetic practices will reopen and what “normal” may look like in a post COVID-19 world including a growing role for virtual consults and peer-to-peer training.

What’s the future for clinical trials? Experts discuss how they’re preparing now for when they can reopen and restart clinical trials in the future. They share ideas for what new protocols and changes will be in place.

Some clinical trials are making due with virtual patient interactions while others are at least temporarily on hold. Experts discuss how trials are adapting and discuss the potential impact on future developments. Featuring: Macrene Alexiades, MD, PhD; Jeffrey S. Dover, MD; Roy G. Geronemus, MD; David H. McDaniel, MD; and E. Victor Ross, MD.